Trials / Completed
CompletedNCT04799132
Association Between Body Mass Index and HFNC Therapy Success
Association Between Body Mass Index and High-flow Cannula Therapy Success in Patients With Severe Covid 19 Related Pneumonia. Retrospective Study.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 303 (actual)
- Sponsor
- Clínica del country · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Patients over 18 years of age who are admitted to the Intermediate Care Unit of the Clinica del Country and the Clinica la Colina, with symptoms suggestive of severe pneumonia secondary to COVID-19 infection and acute hypoxemic respiratory failure. The primary outcome will be to determine the relationship between body mass index and high-flow cannula therapy success defined as: No need for mechanical ventilation.
Detailed description
All adult patients over 18 years of age admitted to the intermediate care service of the participating center with suspected SARS-CoV-2 pneumonia will be considered as potential candidates for the study. The medical records of patients in our cohort who require high-flow cannula therapy and who met all the inclusion criteria and none of the exclusion criteria will be reviewed.All data will be processed and analyzed using the SPSS 26 software once the study is completed. study sample
Conditions
Timeline
- Start date
- 2020-03-11
- Primary completion
- 2021-03-01
- Completion
- 2021-03-01
- First posted
- 2021-03-16
- Last updated
- 2021-03-16
Locations
1 site across 1 country: Colombia
Source: ClinicalTrials.gov record NCT04799132. Inclusion in this directory is not an endorsement.